Is cataract surgery the best way to lower IOP?

Article

Extraction of cataracts lowers intraocular pressure (IOP) to normal levels in glaucoma patients, and may in fact be a better treatment option than combined surgery, according to a study presented at this year's meeting of the Italian Society of Ophthalmology.

Extraction of cataracts lowers intraocular pressure (IOP) to normal levels in glaucoma patients, and may in fact be a better treatment option than combined surgery, according to data presented at this year's meeting of the Italian Society of Ophthalmology.

Richard L. Lindstrom, MD of Minnesota Eye Consultants, US conducted a retrospective review of 588 eyes undergoing cataract extraction with intraocular lens (IOL) implantation in patients with both glaucoma and cataract.

Dr Lindstrom observed IOP reduction in "most" cases. A mean decrease of 7 mmHg was observed in patients with IOP levels of 23–31 mmHg. Patients with higher preoperative IOP levels showed a greater post-surgical IOP reduction.

Dr Lindstrom concluded that the lens plays a more significant role in the development of glaucoma than had previously been acknowledged and that, therefore, except for in cases of severe glaucoma, cataract surgery alone is an appropriate treatment for lowering IOP.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.